LEAD
Suzhou Sanegene Bio Inc.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 98313499 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Yaling Zhou |
| Attorney Docket Number | T31101381400 |
Timeline
| 2023-12-13 | Application Filed |
| 2023-12-14 | Status: Live/Pending |
| 2023-12-14 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Suzhou Sanegene Bio Inc. |
| Address | No. 99 Jingu Rd, Suzhou Industrial Park Rm301,Bldg 2,Zone B,Phase III of bioBAY Suzhou, Jiangsu CN 215103 |
| Legal Entity Type | Limited Liability Company |
| Legal Entity State | CN |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 052,051,005,018,006,044,046 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Oligonucleotide compounds for use in the targeted delivery of RNAi therapy; Pharmaceutical preparations for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Chemical compounds in the form of a molecular nanoparticle complex that act as a platform for the delivery of RNA-based drugs to biological cells; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED | 2023-12-14 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2024-03-18 | 2 NWOS I:Incoming Correspondence |
| TEAS VOLUNTARY AMENDMENT RECEIVED | 2024-05-08 | 3 PARI I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2024-07-12 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2024-08-02 | 5 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2024-08-02 | 6 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2024-08-02 | 7 GNRN O:Outgoing Correspondence |
| NON-FINAL ACTION WRITTEN | 2024-08-05 | 8 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2024-08-05 | 9 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2024-08-05 | 10 GNRN O:Outgoing Correspondence |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 